A new study suggests that dronabinol, a synthetic form of THC, can effectively reduce agitation in Alzheimer’s patients, offering a potential alternative to current treatments that often come with serious side effects.
A new study suggests that dronabinol, a synthetic form of THC, can effectively reduce agitation in Alzheimer’s patients, offering a potential alternative to current treatments that often come with serious side effects.